Yaroglu Kazanci Selcen, Yesilbas Osman, Ersoy Melike, Kihtir Hasan Serdar, Yildirim Hamdi Murat, Sevketoglu Esra
J Pediatr Endocrinol Metab. 2015 Sep;28(9-10):1183-6. doi: 10.1515/jpem-2015-0056.
Cerebral infarction is one of the serious neurological complications of diabetic ketoacidosis (DKA). Especially in patients who are genetically prone to thrombosis, cerebral infarction may develop due to inflammation, dehydration, and hyperviscocity secondary to DKA. A 6-year-old child with DKA is diagnosed with cerebral infarction after respiratory insufficiency, convulsion, and altered level of consciousness. Femoral and external iliac venous thrombosis also developed in a few hours after central femoral catheter had been inserted. Heterozygous type of factor V Leiden and PAI-14G/5G mutation were detected. In patients with DKA, cerebral infarction may be suspected other than cerebral edema when altered level of consciousness, convulsion, and respiratory insufficiency develop and once cerebral infarction occurs the patients should also be evaluated for factor V Leiden and PAI-14G/5G mutation analysis in addition to the other prothrombotic risk factors.
脑梗死是糖尿病酮症酸中毒(DKA)严重的神经并发症之一。特别是在具有血栓形成遗传倾向的患者中,由于DKA继发的炎症、脱水和血液高黏滞状态,可能会发生脑梗死。一名6岁DKA患儿在出现呼吸功能不全、惊厥和意识水平改变后被诊断为脑梗死。在插入股静脉中心导管数小时后还发生了股静脉和髂外静脉血栓形成。检测到杂合型凝血因子V莱顿突变和纤溶酶原激活物抑制剂-1(PAI-1)4G/5G突变。在DKA患者中,当出现意识水平改变、惊厥和呼吸功能不全时,除了脑水肿外还应怀疑脑梗死,一旦发生脑梗死,除了其他血栓形成危险因素外,还应对患者进行凝血因子V莱顿突变和PAI-1 4G/5G突变分析评估。